United States Vaccine Market Report 2021: Focus on COVID-19, Flu, Adult, Children, Adolescent and Travel Vaccines – ResearchAndMarkets.com – Business Wire

DUBLIN–()–The “2021 Vaccine Market Report” has been added to ResearchAndMarkets.com’s offering.

The U.S. vaccine market is estimated to grow to $25 billion by 2024 with the COVID-19 vaccine market adding $10 billion annually.

New investigational approaches in vaccine research show great promise to expand the vaccine market and treat numerous infectious diseases while utilization of current vaccines increases. The 2021 Vaccine Market Report analyzes major market trends impacting the vaccine industry and discusses key vaccines already in the market including COVID-19, flu, adult, children, adolescent and travel vaccines.

Key points include:

  • New vaccines cost $200-500 million to develop
  • 11% more flu vaccines were distributed during the 2020-2021 flu season than the previous season
  • An estimated 9 million childhood vaccine doses were missed in 2020 due to the pandemic

Key Topics Covered:

  1. Executive Summary
  2. Vaccine Market Overview
  3. The Four Main Vaccine Categories (Or Classifications)
  4. Nucleic Acid Vaccines Being Investigated For Future Use
  5. COVID-19 Vaccines Receive First EUAs Using mRNA
  6. Global Cancer Vaccine Market Expected To Grow To $24.3 Billion By 2030
  7. New Vaccines Cost $200-500 Million To Develop
  8. Insurance Or Government Programs Cover Most Recommended Vaccines
  9. 2021 Global COVID-19 Vaccine Market Valued At $40 Billion
  10. Many Americans Hesitant To Receive COVID-19 Vaccine
  11. U.S. Influenza Vaccine Market Estimated To Reach $8.6 Billion By 2027
  12. 2020-2021 Flu Season Has Lowest Infection Rate Since 2005
  13. U.S. Pediatric Vaccine Market Projected To Exceed $15 Billion By 2027
  14. Children’s Vaccination Rates Decline During COVID-19
  15. Childhood Vaccination Rates Growing Fastest For Flu And Rotavirus
  16. Global HPV Market Worth $3.3 Billion; Meningococcal Vaccine Market $1.9 Billion
  17. Adults Require Additional Vaccines As The Immune System Weakens With Age
  18. 76% Of Adults 85 Or Older Vaccinated Against Pneumonia
  19. U.S. 2021 Shingles Vaccine Market Estimated At $1 Billion
  20. Global Travel Vaccine Market Expected To Reach $8.1 Billion By 2024
  21. 95% Of Hospital Workers Received A Flu Vaccine In 2018-2019
  22. Appendices

For more information about this report visit https://www.researchandmarkets.com/r/56jrgo